Pluristem Therapeutics Inc (PSTI)

[skitahoe]

In time I believe it's worth much more than that. I believe approval in any of the diseases they're targeting should bring at least a billion dollar market cap, probably more. Assume 25 million shares outstanding, that's $40 a share for every billion in the market cap.

I believe it it becomes the SOC for pneumonia, Covid-19 and others, a $5 to $10 billion market cap would be justified. I wouldn't be surprised if we either got a partnership or buyout offer once more is know about the covid-19 trial results.

Gary